RxDoctor Payments Data

Kathleen Schurr, DO

Family Medicine · Cary, NCNPI 1215323514

Payments from drug & device makers

$369in general payments, 2019–2025

Across 18 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$104
  • AbbVie$73
  • Astellas Pharma US Inc$41
  • Halozyme Inc$22
  • Abbott$20
  • Exact Sciences$20
  • plus $88 from 5 others

What the payments were for

  • Food & beverage$369100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$369 in reported general payments places this provider in the 50th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$132,690
Medicare patients
287
Services billed
2,026

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide89$93,138
EliquisApixaban63$80,644
OzempicSemaglutide55$60,848
JardianceEmpagliflozin49$50,143
Repatha SureclickEvolocumab54$35,258
MyrbetriqMirabegron39$27,446
XareltoRivaroxaban18$23,311
JanuviaSitagliptin Phosphate14$19,162
VascepaIcosapent Ethyl18$13,578
SynthroidLevothyroxine Sodium113$13,185
MounjaroTirzepatide14$12,857
Victoza 3-PakLiraglutide14$11,013
GemtesaVibegron17$10,800
Levothyroxine Sodium499$8,100
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog23$7,273

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$17$105,995103 claims
PfizerEliquis, Premarin$17$84,66974 claims
Novo NordiskOzempic$104$60,84855 claims
Astellas Pharma US IncMyrbetriq$41$27,44639 claims
AbbVieSynthroid$73$13,185113 claims
Sumitomo Pharma America, Inc.Gemtesa$20$10,80017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Cary

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →